Federal award (BPA CALL, fiscal year 2021)
Recipient: BRILLIENT CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-09-29 to 2023-09-28
Current total value of award: $139652.51
Description: DEVELOPMENT OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELS TO DETERMINE THE OPTIMAL SAFE AND APPROPRIATE DOSE OF ONCOLOGY DRUGS FOR PREGNANT WOMEN WITH CANCER